GSA Capital Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-56,422
| Closed | -$265K | – | 1765 |
|
|
2020
Q3 | $265K | Buy |
+56,422
| New | +$265K | 0.04% | 831 |
|
|
2020
Q2 | – | Sell |
-78,534
| Closed | -$178K | – | 1309 |
|
|
2020
Q1 | $178K | Sell |
78,534
-22,342
| -22% | -$50.6K | 0.04% | 791 |
|
|
2019
Q4 | $463K | Buy |
100,876
+73,250
| +265% | +$336K | 0.05% | 711 |
|
|
2019
Q3 | $107K | Buy |
27,626
+7,859
| +40% | +$30.4K | 0.01% | 1270 |
|
|
2019
Q2 | $119K | Buy |
+19,767
| New | +$119K | 0.01% | 1326 |
|
|
2018
Q4 | – | Sell |
-30,600
| Closed | -$426K | – | 1903 |
|
|
2018
Q3 | $426K | Buy |
+30,600
| New | +$426K | 0.02% | 1150 |
|
|
2018
Q2 | – | Sell |
-33,800
| Closed | -$581K | – | 2037 |
|
|
2018
Q1 | $581K | Buy |
+33,800
| New | +$581K | 0.03% | 986 |
|
|
2017
Q3 | – | Sell |
-27,500
| Closed | -$828K | – | 1966 |
|
|
2017
Q2 | $828K | Sell |
27,500
-16,600
| -38% | -$500K | 0.05% | 693 |
|
|
2017
Q1 | $1.59M | Sell |
44,100
-28,179
| -39% | -$1.02M | 0.09% | 371 |
|
|
2016
Q4 | $3.62M | Buy |
72,279
+1,279
| +2% | +$64.1K | 0.22% | 46 |
|
|
2016
Q3 | $3.73M | Sell |
71,000
-23,425
| -25% | -$1.23M | 0.2% | 57 |
|
|
2016
Q2 | $3.9M | Buy |
94,425
+3,563
| +4% | +$147K | 0.22% | 38 |
|
|
2016
Q1 | $3.69M | Buy |
90,862
+18,662
| +26% | +$758K | 0.24% | 35 |
|
|
2015
Q4 | $3M | Buy |
72,200
+7,086
| +11% | +$294K | 0.15% | 122 |
|
|
2015
Q3 | $1M | Buy |
65,114
+53,085
| +441% | +$817K | 0.05% | 625 |
|
|
2015
Q2 | $299K | Sell |
12,029
-26,867
| -69% | -$668K | 0.01% | 1624 |
|
|
2015
Q1 | $889K | Buy |
+38,896
| New | +$889K | 0.04% | 960 |
|